Crossmark

VCAM-1 as a common biomarker in inflammatory bowel disease and colorectal cancer: unveiling the dual anti-inflammatory and anti-cancer capacities of anti-VCAM-1 therapies

Crossref DOI link: https://doi.org/10.1007/s10555-025-10258-2

Published Online: 2025-03-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pickett, Jessica R.

Wu, Yuao

Ta, Hang Thu
Funding

Funding for this research was provided by:

Griffith University
License Information

Text and Data Mining valid from 2025-03-17

Version of Record valid from 2025-03-17
More Information

Article History

Received: 1 October 2024

Accepted: 4 March 2025

First Online: 17 March 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below